Search

Your search keyword '"Francesca Andreetta"' showing total 5 results
Start Over Author "Francesca Andreetta" Journal journal of the neurological sciences
5 results on '"Francesca Andreetta"'

1. Dysregulation of myomiRs as common pathogenic feature associated with muscle atrophy in ALS, SMA and SBMA: Evidence from animal models and human patients

Author

Monica Nizzardo, Viviana Pensato, Silvia Bonanno, Michela Taiana, Giuseppe Lauria, Riccardo Masson, Eleonora Giagnorio, Lorenzo Maggi, Renato Mantegazza, Cinzia Gellera, Silvia Fenu, Francesca Andreetta, Paola Cavalcante, Franco Salerno, Davide Pareyson, Stefania Corti, Claudia Malacarne, Eleonora Dalla Bella, Mariarita Galbiati, Cinzia Cagnoli, Stefania Marcuzzo, Angelo Poletti, and Anna Venerando

Subjects
Neurology, Feature (computer vision), business.industry, medicine, Neurology (clinical), medicine.symptom, SMA, business, Neuroscience, Muscle atrophy
Published
2021

2. The challenge of paediatric acquired demyelinating syndromes (ADS) in pediatric age: A case report description and a flow-chart proposal

Author

Sophie Guez, Sergio Barbieri, Francesca Andreetta, Alessandra Tozzo, Nereo Bresolin, Fabio Triulzi, Vera Pacoova Dal Maschio, Carlo Agostoni, Mattia Pozzato, Robertino Dilena, and Filippo Martinelli Boneschi

Subjects
Pediatrics, medicine.medical_specialty, Neurology, Flow chart, business.industry, Medicine, Pediatric age, Neurology (clinical), business
Published
2021

3. Expanding clinical spectrum of Caspr2 antibody-associated disease: warning on brainstem involvement and respiratory failure

Author

Paolo Pozzi, Davide Rossi Sebastiano, Daniele Cazzato, Silvia Cenciarelli, Francesco Deleo, Roberta Di Giacomo, Francesca Andreetta, Giuseppe Didato, Flavio Villani, Marco de Curtis, and Chiara Pastori

Subjects
Autoimmune encephalitis, medicine.medical_specialty, Ataxia, business.industry, Limbic encephalitis, Dysautonomia, Disease, medicine.disease, 03 medical and health sciences, 0302 clinical medicine, Neurology, Respiratory failure, Internal medicine, Medicine, 030212 general & internal medicine, Neurology (clinical), Respiratory system, medicine.symptom, Cognitive decline, business, 030217 neurology & neurosurgery
Abstract

We report the case of a 68-year-old man who presented with ataxia, insomnia, rapidly developing cognitive decline, seizures and small vessel vasculitis. Both serum and cerebro-spinal fluid samples showed positive titre of anti-CASPR2 antibodies. Limbic encephalitis was diagnosed and immunomodulatory therapy was started with benefit. After one-year follow-up, the patient relapsed with a difficult-to-treat respiratory failure, brainstem involvement, neuropathic pain and severe dysautonomia with esophageal dysfunction. We discuss here the occurrence of life-threating complication such as respiratory dysfunction in CASPR2 limbic encephalitis. Furthermore, we showed different phenotype and treatment response during disease onset compared to relapse. This case expands the clinical spectrum of anti-CASPR2 associated disease, underlying the need for respiratory and sleep evaluation.

Published
2020

4. Non-paraneoplastic voltage-gated calcium channels antibody-mediated cerebellar ataxia responsive to IVIG treatment

Author

Andrea Salmaggi, Francesca Andreetta, Giuseppe Lauria, Andrea Rigamonti, Vittorio Mantero, and Lorenzo Stanzani

Subjects
Male, Cerebellar Ataxia, Diagnosis, Differential, Cerebrospinal fluid, Medicine, Humans, Subclinical infection, Autoantibodies, biology, Cerebellar ataxia, Voltage-dependent calcium channel, business.industry, Calcium channel, Rare entity, Immunoglobulins, Intravenous, Middle Aged, Titer, Lambert-Eaton Myasthenic Syndrome, Treatment Outcome, Neurology, Immunology, biology.protein, Neurology (clinical), Calcium Channels, Antibody, medicine.symptom, business
Abstract

Non-paraneoplastic cerebellar ataxia associated with voltage-gated calcium channel (VGCC) antibodies is a rare entity with only few cases reported in literature. We describe a 60 year-old man with subacute cerebellar ataxia and subclinical Lambert-Eaton myasthenic syndrome (LEMS) in whom VGCC antibodies were detected at high titer in serum and cerebrospinal fluid. Screening for underlying malignancies was negative. Intravenous immunoglobulin treatment led to the improvement of clinical picture and reduction of serum antibody titer over a 13-month follow-up period. We emphasize that VGCC antibodies should be included in the diagnostic work-up of patients with subacute cerebellar ataxia and that treatment with IVIG can improve the clinical picture and prevent disability.

Published
2013

5. Localization of mitochondrial DNA in normal and pathological muscle using immunological probes: A new approach to the study of mitochondrial myopathies

Author

Eric A. Schon, Salvatore DiMauro, Francesca Andreetta, H. J. Tritschler, and Eduardo Bonilla

Subjects
Mitochondrial DNA, Pathology, medicine.medical_specialty, Biopsy, education, Kearns-Sayre Syndrome, DNA, Mitochondrial, Antibodies, Electron Transport Complex IV, Muscular Diseases, Mitochondrial myopathy, Reference Values, medicine, Humans, Pathological, Anti dna, Ophthalmoplegia, biology, medicine.diagnostic_test, Muscles, Antibodies, Monoclonal, medicine.disease, Immunohistochemistry, humanities, Mitochondria, Muscle, Succinate Dehydrogenase, Neurology, biology.protein, Neurology (clinical), Antibody, Molecular probe
Abstract

We have studied the usefulness of anti-DNA antibodies to detect ragged-red fibers (RRF) in muscle biopsies from patients with mitochondrial myopathies. We have found that these antibodies are excellent probes for the localization of mitochondrial DNA (mtDNA) in RRF, and for the diagnosis of depletion of mtDNA in a newly described group of fatal myopathies of infancy.

Published
1991

Catalog

Books, media, physical & digital resources
See catalog results